Skip to main content
Premium Trial:

Request an Annual Quote

Linguamatics Announces $10M in 2013 Sales

Premium

Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.

The company said in a statement that its increased sales came from a "boost in new customers and increased software licenses to existing customers in the pharmaceutical and healthcare sectors." This included 130 percent growth in healthcare sales plus increased sales in professional services, Linguamatics said.

Linguamatics developed and sells I2E, a software platform that uses natural language processing to identify and extract information from unstructured text such as scientific literature, patents, clinical trials data, electronic health records, news feeds, social media, and proprietary content and put it into a structured format for further analysis.

The company's customer base includes pharmaceutical companies, the US Food and Drug Administration, hospitals, cancer institutes, and academic research centers.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.